@article{8832f2eb6b604684805500079880b4a4,
title = "Key Highlights From the American Association for Bronchology and Interventional Pulmonology Evidence-Informed Guidelines and Expert Panel Report for the Management of Indwelling Pleural Catheters",
keywords = "catheter, effusion, guideline, malignant, pleural, United States, Humans, Pulmonary Medicine, Pleurodesis, Catheters, Indwelling",
author = "Miller, \{CDR Russell J.\} and Chrissian, \{Ara A.\} and Lee, \{Y. C.Gary\} and Rahman, \{Najib M.\} and Wahidi, \{Momen M.\} and Alain Tremblay and Hsia, \{David W.\} and Almeida, \{Francisco A.\} and Samira Shojaee and Lakshmi Mudambi and Belanger, \{Adam R.\} and Harmeet Bedi and Gesthalter, \{Yaron B.\} and Margaret Gaynor and MacKenney, \{Karen L.\} and Lewis, \{Sandra Zelman\} and Casal, \{Roberto F.\}",
note = "Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: N. M. R. has received personal fees for consultancy work and an unrestricted educational grant from Rocket Medical and was the lead investigator of the MIST-2 trial, funded by unrestricted educational grant from Roche UK. Y. C. G. L was the lead investigator of AMPLE-1, -2 and currently -3. Rocket Medical provided free drainage equipment for participants in these multicenter randomized trials. He also served on the advisory board of CareFusion/BD (manufacturer of PleurX catheter) and has received an unrestricted educational grant from Rocket Medical UK for support of AMPLE-2. Additionally, he was a co-Investigator of the MIST-2 trial, funded by an unrestricted educational grant from Roche UK. A. T. was a consultant for, and receipt of royalties for intellectual property from BD Inc. (manufacturer of PleurX catheter). None declared (R. J. M., A. A. C., M. M. W., D. W. H., F. A. A., S. S., L. M., A. R. G., H. B., Y. B. G., M. G., K. L. M., R. F. C., S. Z. L.). FUNDING/SUPPORT: These guidelines were commissioned and funded solely by the American Association for Bronchology and Interventional Pulmonology. Funding Information: FINANCIAL/NONFINANCIAL DISCLOSURES: The authors have reported to CHEST the following: N. M. R. has received personal fees for consultancy work and an unrestricted educational grant from Rocket Medical and was the lead investigator of the MIST-2 trial, funded by unrestricted educational grant from Roche UK. Y. C. G. L was the lead investigator of AMPLE-1, -2 and currently -3. Rocket Medical provided free drainage equipment for participants in these multicenter randomized trials. He also served on the advisory board of CareFusion/BD (manufacturer of PleurX catheter) and has received an unrestricted educational grant from Rocket Medical UK for support of AMPLE-2. Additionally, he was a co-Investigator of the MIST-2 trial, funded by an unrestricted educational grant from Roche UK. A. T. was a consultant for, and receipt of royalties for intellectual property from BD Inc. (manufacturer of PleurX catheter). None declared (R. J. M., A. A. C., M. M. W., D. W. H., F. A. A., S. S., L. M., A. R. G., H. B., Y. B. G., M. G., K. L. M., R. F. C., S. Z. L.). ",
year = "2021",
month = mar,
doi = "10.1016/j.chest.2020.09.282",
language = "English",
volume = "159",
pages = "920--923",
journal = "Chest",
issn = "0012-3692",
number = "3",
}